Not only does the hypoxic tumor promote regulatory T cell (Treg) homing to the TME, but tumor-derived CD4+CD25+FoxP3+ Tregs have been found to be more suppressive of cytotoxic lymphocytes (CTLs) than normal Tregs (48–50). The gene discussed is FOXP3; the disease is neoplasm.